FDA approves voxelotor (Oxbryta) for sickle cell disease
apha.us/2LghYN5
Adalimumab-afzb, biosimilar to Humira, approved for multiple inflammatory conditions
apha.us/2pRaysn
Acalabrutinib now approved for treatment of adults with CLL, SLL
apha.us/2QWAJsR
Riluzole oral film approved for patients with ALS
apha.us/2qNPRhc
Givosiran approved for acute hepatic porphyria
apha.us/2OhuGgC
Cefiderocol approved to treat complicated urinary tract infections
apha.us/2KUjjZP
FDA approves cenobamate tablets for adults with partial-onset seizures
apha.us/2OnqaNL
Crizanlizumab-tmca (Adakveo), first targeted therapy, approved for patients with painful complication of sickle cell disease
https://nitter.gq/t.co/TVZ0Mkrt5z
New agent, #zanubrutinib (#Brukinsa), targets mantle cell lymphoma in adults who've received at least one prior therapy
https://nitter.gq/t.co/Fy0WAqtil9
FDA approves luspatercept–aamt (Reblozyl), first therapy for beta thalassemia, a rare blood disorder
https://nitter.gq/t.co/qcuwI8Nq9v
FDA approves Talicia, three-drug combination to treat H. pylori infection
https://nitter.gq/t.co/tBmQ9jvZXJ
First asenapine transdermal patch approved for treatment of adults with schizophrenia
https://nitter.gq/t.co/AIbSXCRQD9
FDA approves Xofluza for people at high risk of developing flu-related complications
https://nitter.gq/t.co/7NvtCvloxU
Ustekinumab has new indication for treatment of adults with ulcerative colitis
https://nitter.gq/t.co/XJepSD7Vu9
Niraparib approved for late-line treatment of women with recurrent ovarian cancer
https://nitter.gq/t.co/jG8sv2Bf6t